FlexCare Clinical Research, LLC Forms
FlexCare Clinical Research, LLC (FlexCare) announced formation of the company, a clinical service provider focused on providing study visits in the home or alternate site settings via a network of clinicians.
FlexCare was created to meet demand from the biopharmaceutical industry to accelerate clinical trials and streamline study processes. Traditionally, clinical trials are conducted at investigative sites such as hospitals or clinics, where subjects are required to travel for protocol-related tests and assessments throughout the duration of the study. Consequently, for decades, subject recruitment and retention have become challenges in the timely completion of clinical trials. FlexCare’s service model is designed to take the study to the subject, where protocol activities can be conducted in their home or at other alternate locations. FlexCare’s services also hope to benefit pediatric or geriatric subjects, students and working adults who find participation in traditional studies inconvenient.
FlexCare centrally manages study visits that are conducted by its network of clinicians. Services offered by FlexCare include study drug administration, blood draws and other biologic sample collections, clinical assessments, questionnaires and training at the subject’s home or other convenient location.
With the company’s launch, Gail Adinamis was named to the role of chief executive officer. Concurrent with Adinamis’ appointment, Dr. Gizelle Baker was named chief operating officer and Dr. Debbie Wilkerson, chief scientific officer.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
